The latest thoracic oncology news
Depression linked to deadly inflammation in lung cancer patients
Lung cancer patients with moderate to severe depression are 2 to 3 times more likely…
Browsing: Lung Cancer
Death rates from lung cancer will fall overall in the EU and UK in 2023, but rise among women in France, Italy and Spain
A total of 1,261,990 people will die from cancer in 2023 in the EU (EU-27).…
Study identifies new test to accurately predict end of life for lung cancer patients
Lung cancer patients can have their risk of dying accurately predicted within the last four…
NMPA conditionally approves gumarontinib for treatment of non-small cell lung cancer with MET Exon 14 skipping mutation
Gumarontinib, an oral highly selective mesenchymal-epithelial transition (MET) inhibitor and a Category 1 innovative new…
Despite misperceptions, hormone therapy may actually reduce risk of lung cancer
Controversies surrounding hormone therapy (HT) and its benefits and risks have dominated the women’s health…
RANZCR urges the Federal Government to implement the recommendations of the National Dust Diseases Taskforce
The Royal Australian and New Zealand College of Radiologists (RANZCR) urges the Federal Government to…
Lung cancer screening more cost effective when using risk model-based strategies
Risk model-based lung cancer screening strategies, which select individuals based on personal risk, are more cost effective…
Why lung cancer doesn’t respond well to immunotherapy
Immunotherapy — drug treatment that stimulates the immune system to attack tumours — works well…
Research team present fundamental technology to remove metastatic traits from lung cancer cells
KAIST (President Kwang Hyung Lee) have announced that a research team led by Professor Kwang-Hyun Cho…
FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer
On January 26, 2023, the Food and Drug Administration (FDA) approved pembrolizumab for adjuvant treatment following…